What is DirectMed?
DirectMed operates as a specialized manufacturer of plastic components, serving as a vital link in the medical device ecosystem. By providing custom and OEM solutions, the company enables medical device manufacturers to streamline product development and optimize complex supply chains. Their portfolio, which includes essential components for IV-lines and fluid management systems, is underpinned by ISO 13485 certification. This regulatory adherence ensures that their Mexico-based manufacturing operations meet the rigorous quality standards required by healthcare providers worldwide, solidifying their reputation as a reliable partner for large-scale medical infrastructure projects.
How much funding has DirectMed raised?
DirectMed has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in DirectMed
PPP
Public-Private Partnership
What's next for DirectMed?
With this recent infusion of capital, DirectMed is poised to accelerate its operational scaling and enhance its manufacturing footprint. The strategic focus will likely shift toward increasing production capacity and integrating advanced automation to maintain competitive margins in the medical disposables market. By capitalizing on its established expertise and robust quality management systems, the company is prepared to capture additional market share, further cementing its role as an indispensable supplier to the global healthcare industry. Future growth will be driven by the continued expansion of its OEM service offerings and the optimization of its logistics network to better serve international clients.
See full DirectMed company page
